Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as the
cause of a global pandemic. Infection with SARS-CoV-2 can result in COVID-19 with both …

This study is a successor of our previous work concerning changes in the chemokine profile
in infection that are associated with different SARS-CoV-2 genetic variants. The goal of our …

Coronavirus disease 2019 (COVID-19) is characterized by a broad spectrum of clinical
symptoms. After acute infection, some subjects develop a post-COVID-19 syndrome known …

The COVID-19 pandemic, promoted by the SARS-CoV-2 respiratory virus, has resulted in
widespread global morbidity and mortality. The immune response against this pathogen has …

People with diabetes are more likely to have severe COVID-19 compared to the general
population. Moreover, diabetes and COVID-19 demonstrate a certain parallelism in the …

OBJECTIVE: Dupilumab (Dupixent®) is a monoclonal antibody that inhibits IL-4 and IL-13
signaling used for the treatment of allergic diseases. Whilst biologic therapy is traditionally …

Well-trained T-cell immunity is needed for early viral containment, especially with the help of
an ideal vaccine. Although most severe acute respiratory syndrome coronavirus 2 (SARS …

Background Research in the subject of the influence of SARS-CoV-2 mechanisms on
human's homeostasis remains actual problem. Particular interest is the study of …

Abstract The Qingfei Paidu decoction (QFPDD) is a widely acclaimed therapeutic formula
employed nationwide for the clinical management of coronavirus disease 2019 (COVID-19) …